Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Therapeutics Market Research Reports
- Infectious Diseases Therapeutics
- cancer therapeutics
- Dermatology therapeutics
- Ophthalmology therapeutics
- Hematology Therapeutics
- Gastrointestinal therapeutics
- Women's Health therapeutics
- Dental Therapeutics
- Neurology therapeutics
- Respiratory therapeutics
- Diabetes Therapeutics
- Men's Health therapeutics
- Cardiovascular therapeutics
- Central Nervous System (CNS) therapeutics
- Urology therapeutics
- Kidney
- Sexually Transmitted Diseases Therapeutics
- Metabolic therapeutics therapeutics
- Pulmonary therapeutics
- Orthopedic therapeutics
- Arthritis therapeutics
- Oral Therapeutics
- Allergy therapeutics
- ENT Therapeutics
- Radiology therapeutics
- Hiv/Aids Therapeutics
Therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021By Global Markets Direct "...... the therapeutics under development for Muscle Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Act......" | 30-Apr-2021 | $2000 | |
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... vides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Metastatic Ho......" | 30-Apr-2021 | $2500 | |
Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021By Global Markets Direct "...... ides comprehensive information on the therapeutics under development for Muscle Wasting Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report als......" | 30-Apr-2021 | $2000 | |
Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... therapeutics under development for Metastatic Liver Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacologic......" | 30-Apr-2021 | $2000 | |
Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... comprehensive information on the therapeutics under development for Androgen-Sensitive Prostate Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The repo......" | 30-Apr-2021 | $2000 | |
Metastatic Melanoma (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... s under development for Metastatic Melanoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the......" | 30-Apr-2021 | $2500 | |
Ductal Carcinoma In Situ (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... the therapeutics under development for Ductal Carcinoma In Situ, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacol......" | 30-Apr-2021 | $2000 | |
Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Metastatic Ovarian Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharm......" | 30-Apr-2021 | $2000 | |
Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... ipeline landscape.
The report provides comprehensive information on the therapeutics under development for Nongerminomatous (Nonseminomatous) Germ Cell Tumors, complete with analysis by Stage of Development, Drug Target, Mechanism of Act......" | 30-Apr-2021 | $2000 | |
Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... ormation on the therapeutics under development for Metastatic Pancreatic Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descr......" | 30-Apr-2021 | $2000 | |
| | |||